Lexicon’s once-rejected diabetes drug is questioned again by FDA ahead of adcomm

The FDA is raising repeat safety and efficacy questions ahead of an advisory committee meeting on Thursday for Lexicon Pharmaceuticals’ SGLT2 inhibitor sotagliflozin, which the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Comprehensive study reveals global total fertility rate more than halved since 1950

Comprehensive estimates of past and future trends in fertility across 204 nations and territories from 1950 to 2100.

March 26, 2024

XTX-301 by Xilio Therapeutics for Solid Tumor: Likelihood of Approval – Pharmaceutical Technology

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

December 5, 2023

Study of cow tissues provides clues for unusual pattern of bird flu infections in dairy cattle

A new study looking at the distribution of receptors that flu viruses can attach to in different cow tissues may help to explain the pattern

May 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.